Orthofix Medical (OFIX) Cost of Revenue (2010 - 2026)

Orthofix Medical's Cost of Revenue history runs 17 years deep, the most recent figure standing at $57.2 million for Q1 2026.

• Quarterly Cost of Revenue fell 20.64% year-over-year to $57.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $241.4 million (down 8.64% YoY) and the FY2025 annual result came in at $256.3 million, up 1.06% from the prior year.
• Cost of Revenue was $57.2 million for Q1 2026 at Orthofix Medical, down from $63.6 million in the prior quarter.
• Across five years, Cost of Revenue topped out at $72.0 million in Q1 2025 and bottomed at $28.3 million in Q1 2022.
• A 5-year average of $55.9 million and a median of $63.6 million in 2025 frame the typical range for Cost of Revenue.
• Annual changes were most pronounced in 2023 — Cost of Revenue surged 129.09% — and 2026, when it slipped 20.64%.
• Orthofix Medical's Cost of Revenue stood at $33.1 million in 2022, then surged by 92.98% to $63.8 million in 2023, then gained by 4.75% to $66.8 million in 2024, then decreased by 4.86% to $63.6 million in 2025, then slipped by 10.08% to $57.2 million in 2026.
• Business Quant data shows OFIX's Cost of Revenue at $57.2 million in Q1 2026, $63.6 million in Q4 2025, and $57.1 million in Q3 2025.